Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

News Daily News

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

Michael O'Riordan

December 21, 2020

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Review Spotlights SCAD Diagnosis and Treatment

L.A. McKeown

December 15, 2020

News Daily News

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Michael O'Riordan

December 07, 2020

News Daily News

Even Low-Dose Steroids Increase the Risk of CVD

Michael O'Riordan

December 03, 2020

News Daily News

More Women Than Men Develop HF or Die After STEMI

L.A. McKeown

December 01, 2020

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

News Conference News AHA 2020

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

Michael O'Riordan

November 13, 2020

News Daily News

Hostility After ACS Linked to All-Cause Mortality

Michael O'Riordan

September 21, 2020

News Conference News

Blood Pressure Insights in COVID-19: Watch for Drops and RAAS Red Flags

L.A. McKeown

September 10, 2020

News Daily News

US Sees Drop in Hypertension Control

Todd Neale

September 10, 2020

News Conference News ESC 2020

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Michael O'Riordan

September 01, 2020

News Conference News ESC 2020

Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC

Shelley Wood

August 31, 2020

News Daily News

GATEWAY at 3 Years: Bariatric Surgery Continues to Reduce Need for Antihypertensive Drugs

L.A. McKeown

August 31, 2020

News Daily News

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

Yael L. Maxwell

August 19, 2020

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

L.A. McKeown

August 12, 2020

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

News Daily News

Rural-Urban Gap Widens for Cardiometabolic Health Disparities

Michael O'Riordan

June 22, 2020

News Daily News

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

Shelley Wood

May 29, 2020

News Daily News

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Yael L. Maxwell

May 21, 2020

Advertisement

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Review Spotlights SCAD Diagnosis and Treatment

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Even Low-Dose Steroids Increase the Risk of CVD

More Women Than Men Develop HF or Die After STEMI

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

Hostility After ACS Linked to All-Cause Mortality

Blood Pressure Insights in COVID-19: Watch for Drops and RAAS Red Flags

US Sees Drop in Hypertension Control

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC

GATEWAY at 3 Years: Bariatric Surgery Continues to Reduce Need for Antihypertensive Drugs

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Rural-Urban Gap Widens for Cardiometabolic Health Disparities

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content